SM-102: From Lipid Design to Assay Decisions

2026-08-23

SM-102 is an ionizable lipid used to build lipid nanoparticle mRNA delivery systems. This evidence-led guide connects its molecular role and handling requirements with machine-learning results, helping researchers design more interpretable formulation and assay workflows.

Intestinal TM6SF2 and the Gut–Liver Axis in MASH

2026-08-22

A 2025 Nature Metabolism study shows that intestinal TM6SF2 deficiency can drive MASH by disrupting epithelial barrier function, reshaping the microbiota and increasing gut-derived lysophosphatidic acid signaling to the liver. The work moves TM6SF2 biology beyond hepatocyte lipid handling and identifies microbiota modulation and LPA-receptor blockade as experimentally testable intervention points.

From Sulfonamide SAR to Smarter Delivery

2026-08-21

A translational framework for connecting sulfonamide optimization, CYP 2C9 risk reduction, and DMG-PEG2000-NH2-enabled lipid delivery research without overstating the current evidence.

ARCA Cy3 EGFP mRNA (5-moUTP) Workflow

2026-08-20

ARCA Cy3 EGFP mRNA (5-moUTP) combines direct Cy3 tracking with functional EGFP reporter expression in one transcript. This dual-readout design helps researchers separate cellular uptake, intracellular localization, endosomal escape, and translation during mRNA transfection in mammalian cells.

11β-HSD1, Notch, and NK Cells in Liver Fibrosis

2026-08-20

A 2025 mouse study identifies a dual immunometabolic mechanism by which 11β-HSD1 inhibition reduces liver fibrosis: suppression of Notch signaling and enhancement of natural killer cell-mediated clearance of activated hepatic stellate cells. Its integrated use of biochemical, transcriptomic, and mass-cytometry readouts provides a useful framework for interpreting fibrosis mechanisms, while the TAA model requires careful consideration before translation to MASLD or MASH.

mssVIM–IGF-1R Signaling in Cancer Metastasis

2026-08-19

The reference preprint identifies a macrophage-secreted, N-terminally truncated vimentin variant that promotes breast cancer cell migration through an IGF-1R–RSK–integrin αVβ6 pathway. Its findings connect caspase-dependent protein processing in tumor-associated macrophages with extracellular signaling and suggest that mssVIM may have prognostic value, although the work remains to be independently validated because it is not yet peer reviewed.

UTP, RNA Precision, and the One-Receptor Neuron

2026-08-19

The discovery of TRIM66 as an epigenetic repressor of olfactory receptor choice highlights a central challenge in translational biology: distinguishing precise cell-state regulation from low-level transcriptional noise. This article connects that mechanism to reproducible RNA workflows, showing how UTP Solution (100 mM) can support defined RNA controls, amplification, and synthesis while clarifying the boundaries between enabling reagents and biological causality.

Mechanical Stress, Cytoskeleton, and Autophagy

2026-08-18

PD 173074: From PAAD Drug Signal to Assay Plan

2026-08-18

PD 173074 connects computational drug prioritization in pancreatic adenocarcinoma with experimentally testable FGFR1 and VEGFR2 biology. This guide explains how to translate the Yan et al. study into rigorous kinase, angiogenesis, and cancer research workflows without overstating predictive evidence.

SAN–Cardiac Plexus Assembloids Model Pacemaker Maturation

2026-08-17

The reference study introduces human pluripotent stem cell-derived sinoatrial node–cardiac plexus assembloids that reproduce key structural, molecular, and electrophysiological features of innervation-associated pacemaker maturation. By combining assembloid functional assays with human SAN spatial transcriptomics, the authors identify a CGPO-derived prosaposin–GPR37 signaling program and establish a tractable platform for studying neuro-cardiac control of rhythm.

Ginsenoside Rg1: Neuroimmune Research Workflow

2026-08-17

Build a mechanistic neuroprotection workflow around Ginsenoside Rg1, from solvent preparation and anesthesia challenge to behavioral, inflammatory, synaptic, gut-barrier, and regulatory T-cell readouts. The approach distinguishes broad neuroimmune rescue from single-endpoint apoptosis and inflammation research by testing whether Treg-dependent gut–immune–brain restoration explains the phenotype.

FH1 Small Molecule for iHep Maturation

2026-08-16

FH1 small molecule helps convert iPS-derived hepatocyte-like cells into more functional, mature cultures by improving albumin secretion, morphology, and CYP3A4-associated performance while lowering AFP. This article turns those findings into a practical screening workflow and explains how mature liver models may support carefully controlled gene-regulation assays.

SGC-CBP30: Testing Super-Enhancer Dependency

2026-08-15

SGC-CBP30 is a selective CREBBP/EP300 bromodomain inhibitor for dissecting transcriptional coactivator dependence in epigenetics research. This article translates lung adenocarcinoma findings into a rigorous, tiered assay strategy while clarifying what bromodomain inhibition can—and cannot—prove.

CA-074 Me for Lysosomal Cathepsin B Studies

2026-08-14

CA-074 Me provides a cell-permeable way to test whether cathepsin B activity links lysosomal membrane permeabilization to regulated cell death. This workflow-oriented guide covers dosing, live-cell imaging, apoptosis assay design, selectivity controls, and translation to TNF-α-driven inflammation research.

Biotin-16-UTP: Designing RNA–Protein Assays

2026-08-14

Biotin-16-UTP enables controlled biotin-labeled RNA production for capture, detection, and interaction experiments. This guide connects reagent design to endogenous protein imaging, showing how orthogonal assays can separate RNA binding from native protein localization.